[Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].

  title={[Thrombotic risk factors and antithrombotic treatment in atrial fibrillation].},
  author={Jean-paul Bounhoure},
  journal={Bulletin de l'Academie nationale de medecine},
  volume={195 4-5},
  pages={963-74; discussion 974-7}
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia, and its incidence is rising as the population ages. AF is therefore a growing source of cardiovascular morbidity and mortality due to thromboembolic complications and heart failure. The risk of embolic stroke is multiplied by about 5.6-fold in non rheumatic AF and by 17.6-fold in rheumatic AF Strokes due to AF are often fatal or disabling. Paroxysmal and permanent fibrillation are associated with a similar thromboembolic… CONTINUE READING